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Abstract
Respiratory syncytial virus (RSV) is a leading cause of morbidity and mortality worldwide in
children aged <5 years and older adults with acute lower respiratory infections (ALRIs).
However, few studies regarding the epidemiology of hospitalizations for RSV infection have
been performed previously in China. Here, we aimed to describe the clinical and epidemio-
logic characteristics of hospitalized patients with laboratory-confirmed RSV infection in
eastern China. Active surveillance for hospitalized ALRI patients using a broad case defini-
tion based on symptoms was performed from 2009–2013 in 12 sentinel hospitals in eastern
China. Clinical and epidemiologic data pertaining to hospitalized patients of all ages with
laboratory-confirmed RSV infection by PCR assay were collected and analyzed in this
study. From 2009 to 2013, 1046 hospitalized patients with laboratory-confirmed RSV infec-
tion were enrolled in this study, and 14.7% of patients had subtype A, 24.2% of patients had
subtype B, 23.8% of patients with subtype not performed, and 37.3% of patients had RSV
coinfections with other viruses. RSV and influenza coinfections (33.3%) were the most
common coinfections noted in this study. Moreover, young children aged <5 years (89.1%,
932/1046), particularly young infants aged <1 year (43.3%, 453/1046), represented the
highest proportion of patients with RSV infections. In contrast, older adults aged60 years
(1.1%, 12/1046) represented the lowest proportion of patients with RSV infections among
enrolled patients. The peak RSV infection period occurred mainly during autumn and win-
ter, and 57% and 66% of patients exhibited symptoms such as fever (body temperature
38˚C) and cough separately. Additionally, only a small number of patients were treated
with broad-spectrum antiviral drugs, and most of patients were treated with antimicrobial
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drugs that were not appropriate for RSV infection. RSV is a leading viral pathogen and a
common cause of viral infection in young children aged <5 years with ALRIs in eastern
China. Effective vaccines and antiviral agents targeting RSV are needed to mitigate its
large public health impact.
Introduction
Respiratory syncytial virus (RSV) is a leading cause of viral infection in children and older
adults worldwide, particularly young children aged<5 years [1]. Studies indicate that RSV
infection is associated with high morbidity and mortality rates in children with acute lower
respiratory infections (ALRIs) in both industrialized and developing countries [1–4]. Approxi-
mately 34 million RSV-related ALRIs occur in children under 5 years of age, resulting in at
least 3.4 million hospitalizations and 66,000–199,000 RSV-related deaths, 99% of which occur
in developing countries [1]. RSV infection is responsible for approximately 1/4 of hospitaliza-
tions in children aged<5 years in China [2, 5–9] in areas such as Jingzhou [6], Lanzhou [7],
Hangzhou [8], Suzhou [9], and Hong Kong [2].
Accumulating evidence indicates that RSV is a common cause of severe ALRIs, such as
bronchiolitis and pneumonia, particularly in young children (aged<5 years) and older adults
[10–12]. Safe and effective vaccines are needed to combat the high morbidity and mortality
rates associated with RSV infection, and some candidates are in development. Previous reports
have estimated the prevalence of RSV infection in hospitalized children and adults and deter-
mined that RSV seasons vary by geographic region and that rates of hospitalizations vary by
age [13–16]. However, more data regarding the clinical and epidemiologic characteristics of
RSV infection are needed to develop strategies to prevent and control the disease.
In this study, we aimed to evaluate the epidemiology, clinical characteristics and manage-
ment of ALRIs caused by RSV infection among hospitalized patients of all age groups in east-
ern China between 2009 and 2013 in a hospital-based surveillance study.
Methods and Materials
Ethics Statement
RSV data collection from patients with ALRIs was considered public health surveillanceby the
National Health and Family Planning Commission of the People’s Republic of China. Brief ver-
bal informed consent was obtained from all individuals enrolled in this study, according to the
Declaration of Helsinki (1964), and this study was approved by the Ethics Committee of the
Chinese Center for Disease Control and Prevention (China CDC, Beijing, China).
Case Ascertainment
All subjects with laboratory confirmedRSV infectionwere hospitalized at 12 sentinel hospitals
located in 6 provinces in eastern China between January 2009 and December 2013. Detailed
data pertaining to these patients, including data regarding patient demographic and clinical
characteristics and laboratory results, were obtained from an online data management system
established by the China CDC [17–18]. Patient enrollment, sample collection, laboratory test-
ing, and case reporting were conducted by all sentinel hospitals and laboratories according to a
national surveillanceprotocol [17].
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Patients were admitted to surveillancewards presided over by the departments of pediatrics,
internal medicine, and infectious diseases or to the intensive care units (ICUs) of the above-
mentioned sentinel hospitals and screened by physicians and nurses for ALRI, which was diag-
nosed according to the following criteria: (1) at least one of the followingmanifestations of
acute infection: fever (38°C), abnormal white blood cell (WBC) differentials, leukocytosis
(WBC count more than 10,000/mL) or leukopenia (WBC count less than 4,000/mL), and chills;
and (2) at least one of the following signs/symptoms of respiratory tract infection: cough, spu-
tum production, shortness of breath, lung examination abnormalities (crackles or wheeze),
tachypnea, and chest pain [17–18].
Sample Collection and Testing
Clinical samples, such as nasopharyngeal swabs, aspirates and sputum, were collected and
immediately placed in viral transport medium (VTM) before being stored at 4–8°Cat each sen-
tinel hospital. These specimens were subsequently transferred to the nearest influenza network
laboratory (provincial or prefecture Center for Disease Control and Prevention [CDC]) for
diagnostic testing. Most of the specimens were tested within 24 hours of collection, and any
specimens not tested within 24 hours were stored in VTM at -70°C. All specimens were tested
for RSV (A and B subtypes), human influenza virus, human parainfluenza virus (HPIV),
human bocavirus (HBoV), adenovirus (AdV), rhinovirus (RV), coronavirus (CoV), human
metapneumovirus (HMPV), and enterovirus (EV)by real-time polymerase chain reaction
(PCR), reverse transcriptase PCR (RT-PCR) or real-time RT-PCR, as previously described
[17,19,20].
Data Collection and Statistical Analysis
Detailed data regarding patient demographic and clinical characteristics and laboratory results
were collected by the staff of the sentinel hospitals and laboratories using standardized case
reporting forms and were uploaded into the online data management system. Descriptive sta-
tistics were used to analyze the demographic, epidemiological and clinical characteristics of the
patients with RSV infection. Statistical analysis was performedwith SPSS software (v18.0,
SPSS, Chicago, IL, USA).Wilcoxon tests were used to compare the medians of continuous vari-
ables, and chi-square tests were performed to analyze frequency data. P<0.05 was considered
statistically significant.
Results
Characteristics of RSV Patients
From January 2009 to December 2013, 1046 hospitalized patients with laboratory-confirmed
RSV infections were treated at 12 sentinel hospitals in 6 provinces in eastern China (Fig 1). Of
these patients, 154 (14.7%) were diagnosedwith RSV-A, 253 (24.2%) were diagnosedwith
RSV-B, 249 (23.8%) were subtyping not performed, and 390 (37.3%) were diagnosedwith coin-
fections with RSV and other respiratory tract viruses (Fig 2A). Influenza virus (48.7%, 190/
390) was the most common infectious agent noted in patients mixed infections, and coinfec-
tions with RSV/influenza (33.3%, 130/390) were the most frequent coinfections noted in this
study, as 13 patients were diagnosedwith RSV-A and influenza, 9 patients were diagnosedwith
RSV-B and influenza, and 108 patients were diagnosedwith RSV subtyping not performed and
influenza. Furthermore, 61 (15.6%) and 52 patients (13.3%) were diagnosedwith RSV and
HPIV or RSV and AdV coinfections, respectively (Fig 2B).
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Fig 1. Locations of the 12 sentinel hospitals in eastern China at which respiratory syncytial virus
(RSV) patients were treated. The red numbers indicate the locations of the surveillance sites. A total of 12
sentinel hospitals located in six provinces were enrolled in the final RSV infection analysis. 1). Children’s
Hospital of Shanghai, Shanghai Jiao Tong University; 2). Children’s Hospital of Fudan University; 3). Huzhou
Central Hospital, Zhejiang Province; 4). The First Affiliated Hospital, School of Medicine, Zhejiang University;
5). The Children’s Hospital, School of Medicine, Zhejiang University; 6). Zhejiang Provincial Center for
Disease Control and Prevention; 7). Renmin Hospital of Wuhan University; 8). Tongji Hospital, Tongji
Medical College, Huazhong University of Science & Technology; 9). Wuhan Women and Children Medical
Care Center, Hubei Province; 10). Jiangxi Provincial Children’s Hospital; 11). Maternal and Children’s Health
Hospital of Fujian Province; 12). Hunan Provincial People’s Hospital.
doi:10.1371/journal.pone.0165437.g001
Fig 2. Patients with laboratory-confirmed RSV infection. (A) Distributions of RSV subtypes and
coinfections among 1046 patients. (B) Distributions of other viral infections among 390 patients with RSV
coinfections. *Others indicated RSV+HBoV+RV, RSV+EV, RSV+CoV, or RSV+HMPV, as less than 13
cases of each were noted. HPIV, human parainfluenza virus; HBoV, human bocavirus; AdV, adenovirus; RV,
rhinovirus; CoV, coronavirus; HMPV, human metapneumovirus; EV, enterovirus.
doi:10.1371/journal.pone.0165437.g002
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Gender and Age Distributions of RSV Patients
In this study, 671 (64.1%) of the enrolled patients were male, and no significant differences
were observedbetweenmen and women with the respect to the incidences of RSV-A and
RSV-B infections and coinfections (Table 1). RSV infectionwas more common in young chil-
dren aged<5 years (89.1%, 932/1046) than in patients aged5 years (11.9%, 114/1046).
RSV-A (85.1%, 131/154), RSV-B (90.9%, 230/253), subtyping not performed (87.1%, 217/249)
and RSV coinfection (83.3%, 325/390) were also more common in young children than in
other patients. Moreover, RSV infectionwas more common in young infants aged<6 months
(26.8%, 280/1046) than in other patients. RSV-A (40.0%, 60/154), RSV-B (39.5%, 100/253),
and subtyping not performed (22.1%, 55/249) were also more common in this age group than
in other age groups. Additionally, the median age of patients with RSV single-infections (8–12
months) was considerably lower than that of patients with coinfections (24 months)
(P = 0.000, Mann-Whitney Test). RSV infection exhibited a gradually decreasing trends with
increasing age, as did RSV-A, RSV-B, and subtyping not performed and coinfections.
Temporal/Seasonal Trends of RSV
RSV infection exhibited clear seasonal trends during this study. The majority of RSV infections
occurred between September 2010 and February 2011 (Fig 3A). RSV-A infections were most
frequently observed in spring, autumn and winter from January to March 2010, July 2011 to
May 2012, and January to February 2013 (Fig 3B). Similarly, RSV-B infections were most fre-
quently observedbetween January and April in 2009, 2010 and 2013 (Fig 3C). Moreover, RSV
with subtyping not performed and RSV coinfections were most frequently observedbetween
October 2010 and February 2011 (Fig 3D) and between September 2010and February 2011
(Fig 3E) compared with other seasons, respectively.
Clinical Characteristics of RSV Patients
A temperature of38°C was documented in 61.0% of patients with RSV infection, and 59.0%
of patients with RSV coinfectionwith other viruses at the time of physical examination. A mod-
erately significant difference in temperature was observedbetween patients with RSV
Table 1. Gender and age distributions of patients with laboratory-confirmed RSV infection.
Characteristics Total (n = 1046) RSV-A (n = 154) RSV-B (n = 253) Subtyping not performed (n = 249) Coinfections (n = 390)
Male 671 (64.1%) 96 (62.3%) 156 (61.7%) 168 (67.5%) 251 (64.3%)
Female 375 (35.9%) 58 (37.7%) 97 (38.3%) 81 (32.5%) 139 (35.6%)
Age (Years, M, QR) 1 (0.4–3) 0.8 (0.2–1) 0.8 (0.3–2) 1 (0.5–3) 2 (0.8–3)
Age group
0–5 m 280 (26.8%) 60 (40.0%) 100 (39.5%) 55 (22.1%) 65 (16.7%)
6–11 m 173 (16.5%) 29 (18.8%) 42 (16.6%) 53 (21.3%) 49 (12.5%)
1 y 199 (19.0%) 27 (17.5%) 45 (17.8%) 51 (20.5%) 76 (19.5%)
2 y 98 (9.4%) 6 (3.9%) 13 (5.1%) 25 (10.0%) 54 (13.8%)
3 y 97 (9.3%) 4 (2.6%) 17 (6.7%) 23 (9.2%) 53 (13.6%)
4 y 56 (5.4%) 5 (3.2%) 13 (5.1%) 10 (4.0%) 28 (7.2%)
5 y 29 (2.8%) 1 (0.6%) 4 (1.6%) 7 (2.8%) 17 (4.4%)
6–9 y 66 (6.3%) 3 (1.9%) 13 (5.1%) 12 (4.8%) 36 (9.2%)
10–14 y 16 (1.5%) 2 (1.3%) 1 (0.4%) 7 (2.8%) 7 (1.8%)
15–59 y 20 (1.9%) 10 (6.5%) 1 (0.4%) 5 (2.0%) 5 (1.3%)
60 y 12 (1.1%) 7 (4.5%) 4 (1.6%) 1 (0.4%) 0 (0%)
doi:10.1371/journal.pone.0165437.t001
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coinfections and patients with RSV single-infections (χ2 = 4.825, P = 0.028). Coughwas the
most common symptom exhibited by RSV patients (66.3%), and runny nose (22.7%) and spu-
tum production (18.6%) were also common among affected patients. Moreover, significant dif-
ferences between patients with RSV coinfections with other viruses and patients with RSV
single-infectionswere observedwith respect to symptoms such as cough (χ2 = 5.774, P = 0.016),
runny nose (χ2 = 8.749, P = 0.003), sore throat (χ2 = 10.357, P = 0.001), sputum production
(χ2 = 8.063, P = 0.005), shortness of breath (χ2 = 27.700, P = 0.000), and difficulty breathing
(χ2 = 5.920, P = 0.015), as well as WBC count (χ2 = 0.015, P = 0.903). Moreover, the patients
with RSV and influenza coinfection had highest rate in clinical symptoms as sore throat
(18.4%), shortness of breath (8.4%) and/or difficulty breathing (11.1%). Of 803 patients who
underwent a chest X-ray, 168 (20.9%) were found to have radiographic evidence of pneumonia,
although the proportion of the patients with pneumonia/RSV coinfectionwas not significantly
different from that of patients with RSV single-infection (χ2 = 0.653, P = 0.419) (Table 2).
Analysis of Drug Administration
Currently, only a few drugs exist effective against RSV infections or other viral infections.
Many antimicrobial drugs were used by doctors to treat patients in this study. Of 147 patients
with RSV infection, 102 were treated with one drug. Amoxicillin-clavulanate (23.5%, 24/102)
was the most frequently prescribed antibacterial drug, and Cefuroxime (17.6, 18/102) was the
Fig 3. Seasonal trends of laboratory-confirmed RSV infection in hospitalized patients in eastern China between
2009 and 2013. (A) RSV infection; (B) RSV-A; (C) RSV-B; (D) Subtyping not performed; (E) Coinfection with other viruses.
doi:10.1371/journal.pone.0165437.g003
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Table 2. Clinical characteristics of patients with laboratory-confirmed RSV infection.
Characteristics Total (n = 1046) RSV-A
(n = 154)
RSV-B
(n = 253)
Subtyping not performed
(n = 249)
Coinfection (n = 390)
Influenza
(n = 190)
No Influenza
(n = 200)
Symptoms and Signs
Fever38˚C 571/1003
(56.9%)
80 (51.9%) 119 (47.0%) 142 (57.0%) 113 (59.4%) 117 (55.4%)
Cough 694 (66.3%) 124 (80.5%) 215 (85.0%) 114 (45.8%) 103 (54.2%) 138 (69%)
Runny nose 237 (22.7%) 52(33.8%) 73 (28.9%) 43 (17.3%) 32 (16.8%) 37 (18.5%)
Sore throat 93 (8.9%) 11 (7.1%) 3 (1.2%) 30 (12.0%) 35 (18.4%) 14 (7%)
Sputum production 195 (18.6%) 39 (25.3%) 25 (9.9%) 41 (16.5%) 31 (16.3%) 59 (29.5%)
Shortness of breath 37 (3.5%) 2 (1.3%) 2 (0.8%) 4 (1.6%) 16 (8.4%) 13 (6.5%)
Difficulty breathing 55 (5.3%) 9 (5.8%) 7 (2.8%) 10 (4.0%) 21 (11.1%) 8 (4%)
Headache 71 (6.8%) 18 (11.7%) 4 (1.6%) 19 (7.6%) 12 (6.3%) 18 (9%)
Fatigue 33 (3.2%) 10 (6.5%) 7 (2.8%) 6 (2.4%) 8 (4.2%) 2 (1%)
Abdominal pain 5 (0.4%) 2 (1.3%) 0 0 0 3 (1.5%)
Diarrhea 13 (1.2%) 5 (3.2%) 4 (1.6%) 0 0 4 (2%)
Clinical Examinations
Lung auscultation 122/603
(20.2%)
19 (12.3%) 46 (18.2%) 12 (4.8%) 12 (6.3%) 33 (16.5%)
Abnormal X-ray 168/803
(20.9%)
36 (23.4%) 65 (25.7%) 9 (3.6%) 21 (11.1%) 37 (18.5%)
Laboratory Examinations
Blood routine numbers 453 69 175 41 91 77
WBC (×109/L) 8.8 (6.4–12.14) 8.3 (6.6–
12.12)
8.6 (6.4–10.5) 10.3 (6.6–14.4) 9.3 (6.75–13.25) 9.13 (6.39–12.34)
<4.0 17 (3.7%) 1 (1.4%) 12 (6.9%) 1 (2.4%) 1 (1.1%) 3 (3.9%)
>10.0 173 (38.2%) 27 (39.1%) 52 (29.7%) 22 (53.7%) 40 (44.0%) 32 (41.6%)
L(%) 43 (27–58) 48 (33–58) 50 (36–64) 32(19–52) 32 (20–53) 42 (26–54)
<20% 71 (15.7%) 5 (7.2%) 15 (8.6%) 12 (29.3%) 23 (25.3%) 15 (19.5%))
>40% 257 (56.7%) 45 (65.2%) 118 (67.4%) 16 (39.0%) 39 (42.9%) 39(50.6%)
N(%) 44 (28–60) 39 (27–54) 38 (25–53) 55 (36–74) 55 (34–71) 49 (35–67)
<40% 200 (44.2%) 47 (68.1%) 121 (69.1%) 17 (41.5%) 37 (40.7%) 40 (51.9%)
>70% 67 (14.8%) 5 (7.2%) 11 (6.3%) 11 (26.8%) 26 (28.6%) 14 (18.2%)
PLT (×109/L) 313 (223–409) 336 (223–436) 338 (248–429) 252 (202–413) 272 (210–376) 295 (219–378)
<100 7 (1.5%) 1 (1.4%) 1 (0.6%) 1 (2.4%) 1 (1.1%) 3 (3.9%)
>300 237 (52.3%) 38 (55.1%) 105 (60.0%) 18 (43.9%) 41 (45.1%) 35 (45.5%)
Hb (g/L) 119 (109–129) 116 (104–128) 116 (108–130) 120 (112–128) 118 (113–126) 120 (111–128)
<110 137 (30.2%) 26 (37.7%) 51 (29.1%) 8 (19.5%) 28 (30.8%) 24 (31.2%)
>150 13 (2.9%) 5 (7.2%) 2 (1.1%) 3 (7.3%) 2 (2.2%) 1 (1.3%)
Blood gas analysis
(cases)
104 24 21 8 10 41
pH 7.38 (7.34–
7.41)
7.36 (7.33–
7.4)
7.37 (7.34–
7.4)
7.41 (7.39–7.45) 7.37 (7.33–7.39) 7.38 (7.34–7.42)
<7.35 35 (33.6%) 9 (37.5%) 8 (38.1%) 1 (12.5%) 3 (30%) 14 (34.1%)
>7.45 13 (12.5%) 2 (8.3%) 1 (4.8%) 2 (25.0%) 0 8 (19.5%)
PCO2(mmHg) 31 (25–36) 31 (26–38) 34 (28–38) 32 (28–41) 29 (20–33) 30 (24–33)
<35 77 (74.0%) 15 (62.5%) 15 (71.4%) 4 (50.0%) 8 (80%) 35 (85.4%)
>45 8 (7.7%) 2 (8.3%) 2 (9.5%) 1 (12.5%) 1 (10%) 2 (4.9%)
PO2(mmHg) 83 (67–100) 78 (65–97) 91 (64–99) 86 (65–99) 83 (76–102) 82 (67–99)
<80 45 (43.3%) 14 (58.3%) 10 (47.6%) 4 (50.0%) 3 (30%) 14 (34.1%)
(Continued )
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secondmost frequently prescribed antibacterial drug. Seventy patients were treated with two
drugs with Azithromycin (16.7%, 12/72) and Cefuroxime (13.9%, 10/72) that were the most
frequently prescribed drugs.Moreover, multiple other drugs were also prescribed for patients.
However, broad-spectrumantiviral agents, such as Ribavirin and Potassium sodium dehy-
droandroandrographolide succinate, were not commonly prescribed to patients with RSV
infection. Additionally, some drugs were used excessively and administered for longer time
periods than recommended, such as Azithromycin (whose course is normally limited to 5
days) and Cefuroxime (whose course is normally limited to 7 days) (Table 3).
Discussion
This study is a part of a hospital-basedALRI surveillance study in China and documented the
etiologies, epidemiology and clinical characteristics of ALRIs caused RSV, which was diagnosed
via laboratory testing, using data from a sentinel surveillance system in eastern China. From
2009 to 2013, a total of 1046 hospitalized ALRI patients (children and adults) were treated at
12 sentinel hospitals in eastern China.We found that most patients had RSV single-infections
and that 37.3% had mixed viral infections caused by RSV and other respiratory tract viruses.
Additionally, we observed that coinfections with RSV and influenza were the most frequently
diagnosedmixed infections among our patient population, a finding consistent with those of
previous studies in China [17–21] and other countries [15, 22–26]. Taken together, these find-
ings indicate that coinfectionsmay influence severe illnesses in patients with RSV infections,
especially in young children aged<5 years.
Althoughmany studies regarding RSV have focused on children aged<5 years and elderly
adults, among whom the morbidity and mortality rates of RSV infection are high, little is
known regarding the effects of RSV among patients of all ages. We analyzed the overall age dis-
tributions of the patients with RSV infections. Our results indicated that children aged<5
years represented the largest proportion of patients with RSV infections (86.4%) and coinfec-
tions (83.3%), particularly young children (total: 62.3%; coinfections: 48.7%) aged<2 years,
compared to patients aged5 years. These observations indicate that an association exists
betweenRSV prevalence and age, a finding consistent with those of previous reports in China,
Japan, Thailand and other countries [17–21, 24–27].
Our surveillancedata indicate that RSV infection occurred almost year-round from 2009 to
2013 and peakedmainly during autumn and winter in areas of eastern China with subtropical
climates, results similar to those reported previously in China and other countries [19–24] but
different from those reported in tropical countries [16]. These findings indicate that RSV infec-
tion is characterized by a seasonality that may be associated with regional climate and demo-
graphic factors [6,12,22]. The seasonality of RSV is different in tropical and subtropical
countries; thus, hospitals in these countries can utilize seasonally timed interventions and spe-
cific vaccination and hospital infection control strategies [1,9,13].
Table 2. (Continued)
Characteristics Total (n = 1046) RSV-A
(n = 154)
RSV-B
(n = 253)
Subtyping not performed
(n = 249)
Coinfection (n = 390)
Influenza
(n = 190)
No Influenza
(n = 200)
>100 26 (25.0%) 5 (20.8%) 5 (23.8%) 2 (25.0%) 3 (30%) 11 (26.8%)
SO2(%) 96 (92–98) 95 (91–97) 97 (92–98) 96 (93–98) 96 (94–97) 96 (93–98)
<93 29 (27.9%) 10 (41.7%) 8 (38.1%) 1 (12.5%) 0 10 (24.4%)
>98 14 (13.5%) 2 (8.3%) 4 (19.0%) 2 (25.0%) 1 (10%) 5 (12.2%)
doi:10.1371/journal.pone.0165437.t002
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Most of the patients enrolled in this study had symptoms of fever (temperature38°C) and
cough, and moderately significant differences in temperature and cough were observed
between patients with RSV coinfections and patients with RSV single-infections. These obser-
vations are consistent with those of previous reports [17–19]. A few patients experienced short-
ness of breath or difficulty breathing, the majority of whom suffered from RSV coinfections,
indicating that RSV coinfections with other viruses can cause more severe disease than RSV
single-infections.However, the proportions of patients with pneumonia were not significantly
different between patients with RSV coinfection and patients with RSV single-infection, indi-
cating that pneumonia development was likely related to other factors, such as patient age,
patient physical condition, and viral load [23–28]. Generally, viral infections do not signifi-
cantly affect common laboratory parameters (such as WBC, PO2, and PCO2), particularly dur-
ing their early stages [11, 29–30]. Our data indicated that there were no significant differences
in laboratory parameters between patients with RSV single-infections and patients with
coinfections.
Table 3. Drugs administered to 147 patients with laboratory-confirmed RSV infection.
Drugs Number of drug administrations
One (n = 102) Two (n = 72) Three (n = 24) Four (n = 4)
Antimicrobial drugs
Amoxicillin-clavulanate acid 24 7 1 0
Azithromycin 9 12 2 1
Cefotaxime 10 4 4 0
Meropenem 1 0 0 1
Penicillin 1 0 1 0
Cefuroxime 18 10 3 0
Cefmetazole 2 1 0 0
Cefminox 3 0 0 0
Cefoperazonesulbactam 11 5 2 1
Ceftriaxone 5 8 1 1
Ceftazidime 5 0 0 0
Cefotiam 1 1 1 0
Ceftizoxime 7 1 0 0
Imipenem/cilastatin 1 1 0 0
Ampicillin sulbactam 2 0 1 0
Acetyl midecamycin 0 3 3 0
Mezlocillin 0 1 2 0
Moxifloxacin 0 1 0 0
Cetirizine 0 1 0 0
Teicoplanin 0 3 1 0
Latamoxef 0 2 0 0
Piperacillin/tazobactam 0 1 0 0
Ampicillin 0 1 0 0
Salbutamol 0 0 1 0
Erythromycin 0 0 1 0
Drugs for supportive therapy 0 0 0 0
Terbutaline sulfate 1 4 0 0
Broad-spectrum antiviral drugs 0 0 0 0
Potassium sodium dehydroandroandrographolide succinate 1 4 0 0
Ribavirin 0 1 0 0
doi:10.1371/journal.pone.0165437.t003
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Currently, only a few antivirals exist that are effect against RSV infections and other viral
infections, and delays in viral testing have important effects on infection severity, particularly
among patients with RSV, influenza virus and enterovirus infections [1,11,30]. In our study,
only a few patients with RSV infections were treated with broad-spectrumantiviral drugs
(Ribavirin and Potassium sodium dehydroandroandrographolide succinate) that were not spe-
cific for RSV. Most of the antimicrobial drugs administered to patients in this study were not
appropriate for patients with RSV infection but are commonly used in such patients in China.
It is well known that antimicrobial drug overuse selects for highly resistant organisms, causes
immune dysfunction, and increases viral loads, which may explain the highmorbidity and
mortality rates associated with RSV infection [12, 26–28].
Our study had some limitations. First, patients were tested for RSV and other respiratory
tract viruses, but not bacterial pathogens; thus, our data regarding pathogens causing ALRIs
were not comprehensive. Second, we tested for RSV-A and RSV-B to determine the relation-
ships betweenRSV subtype and age, seasonality and clinical characteristics, but some of total
RSV infections did not test for RSV subtypes. Third, some of our clinical and laboratory data
were not comprehensive, which affected our ability to estimate RSV disease severity.
Conclusion
In summary, this study provided important epidemiologic information regarding RSV and
associated respiratory viral infections in patients with ALRIs in eastern China. RSV infection is
common in young children, and implementing disease control strategies (such as safe vaccina-
tion) during the appropriate seasonsmay have a significant impact on public health. Clinical
and laboratory data pertaining to patients with RSV infectionmay be helpful for optimizing
patient treatments. Timely and accurate diagnosis of RSV infection in patients with ALRIs is
necessary to prevent large-scale RSV spread and to reduce the burden imposed by the disease
and the misuse of antimicrobial drugs. These preliminary results indicate that more surveil-
lance data are needed to estimate the RSV disease burden and to determine whether geographic
locations, climate, other environmental factors and RSV coinfections impact the severity
ofRSV-related epidemics.
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